Pharmacokinetics and pharmacodynamics of insulin: Relevance to the therapy of diabetes mellitus

被引:0
|
作者
Brunetti, P
Bolli, GB
机构
关键词
insulin therapy; pharmacokinetics; pharmacodynamics; hypoglycaemia unawareness;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:24 / 34
页数:11
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus
    Czock, D
    Aisenpreis, U
    Rasche, FM
    Jehle, PM
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2003, 41 (10) : 492 - 497
  • [2] Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus
    Morello, Candis M.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2011, 4 : 827 - 835
  • [3] Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance
    Owens, David R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (08) : 977 - 987
  • [4] Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment
    Alfarisi, Omamah
    Mave, Vidya
    Gaikwad, Sanjay
    Sahasrabudhe, Tushar
    Ramachandran, Geetha
    Kumar, Hemanth
    Gupte, Nikhil
    Kulkarni, Vandana
    Deshmukh, Sona
    Atre, Sachin
    Raskar, Swapnil
    Lokhande, Rahul
    Barthwal, Madhusudan
    Kakrani, Arjun
    Chon, Sandy
    Gupta, Amita
    Golub, Jonathan E.
    Dooley, Kelly E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)
  • [5] Pharmacokinetics and pharmacodynamics of dapagliflozin in children and adolescents with type 2 diabetes mellitus
    Tirucherai, G. S.
    LaCreta, F.
    Ismat, F. A.
    Tang, W.
    Boulton, D. W.
    DIABETES OBESITY & METABOLISM, 2016, 18 (07): : 678 - 684
  • [6] The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus
    Dudkowski, Caroline
    Tsai, Max
    Liu, Jie
    Zhao, Zhen
    Schmidt, Eric
    Xie, Jeannie
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (03) : 279 - 288
  • [7] Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Hiroaki Iijima
    Takayuki Kifuji
    Nobuko Maruyama
    Nobuya Inagaki
    Advances in Therapy, 2015, 32 : 768 - 782
  • [8] The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus
    Caroline Dudkowski
    Max Tsai
    Jie Liu
    Zhen Zhao
    Eric Schmidt
    Jeannie Xie
    European Journal of Clinical Pharmacology, 2017, 73 : 279 - 288
  • [9] Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Iijima, Hiroaki
    Kifuji, Takayuki
    Maruyama, Nobuko
    Inagaki, Nobuya
    ADVANCES IN THERAPY, 2015, 32 (08) : 768 - 782
  • [10] Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes
    S. Luzio
    G. Dunseath
    R. Peter
    V. Pauvaday
    D. R. Owens
    Diabetologia, 2006, 49 : 1163 - 1168